Grand River Aseptic Manufacturing is a sterile injectable CDMO backed by innovative technology, advanced equipment, and experienced team members. With capabilities for biologics, small molecules and vaccines, GRAM delivers solutions for clients’ fill and finish needs.
Recognizes manufacturing facility and processes are in compliance with GMP requirements and readiness to provide commercial aseptic fill/finish services.
As a partner to the U.S. Government, GRAM's newest facility was designed to increase large-scale fill and finish capacity with room to expand as demand grows.
Andrew Kolbert of Avomeen discusses FDA oversight of E&L testing, complications that arise, and the expertise needed to keep up with changing quality standards
Underscores potential for momelotinib to address unmet needs of patients with Intermediate/High-Risk myelofibrosis who have previously received a JAK inhibitor
A group of independent investors, led by the Municipal Employees' Retirement System of Michigan, has invested $9.8 million in Grand River Aseptic Manufacturing